ARCHIVES

In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads

This article is from The Cancer Letter archive.

Vol. 06 No. 32 | August 8, 1980

Download PDF Visit The Full Archive

Related Articles

Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency.

December 19, 2008

In Brief: Hawaii Study finds No Increase Risk for Large Bowell Cancer From High Intake Of Saturated Fat

October 12, 1984

Where’s The Money for Local Programs? Everyone Wants To Know

February 28, 1975

AMA, ACOS, VA Express Interest In Trials; NCI, DCT Board Cool

March 3, 1989

Cancer Prevention: NSABP Publishes P-1 Data, Finds Risk Of Breast Cancer Cut By 49 Percent

September 18, 1998

Federal Regs Prohibit RFP Budget Releases

February 21, 1975